In summary, we have described a combined computational and experimental approach to designing, synthesizing, and evaluating the SAR for new halogenated 2-aminobenzothiazole derivatives as PTR1 and parasite inhibitors. The work offers insights into the molecular basis of inhibitor binding and activity, providing a guide for the further optimization of these compounds for improved therapeutic efficacy and selectivity.